Translated automatically – community improvements welcome.
L-DOPA
L-DOPA is a biochemical precursor of dopamine that is used in the brain to increase dopamine levels. It is primarily employed in the treatment of Parkinson's disease to compensate for dopaminergic deficits. The substance acts indirectly by increasing dopamine availability and thus affects dopaminergic receptors. Side effects may include motor dysfunctions and neuropsychiatric effects. L-DOPA is not a classic stimulant but shows stimulating effects through dopamine enhancement.
Mechanism of Action
- Dopaminvorstufe
Names / Identifiers
IUPAC: L-DOPA
Mechanism of Action
L-DOPA wird im Gehirn in Dopamin umgewandelt, was zu einer Erhöhung der Dopaminverfügbarkeit führt und somit die Symptome der Parkinson-Krankheit lindert.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Severe cardiovascular diseases
- Acute psychoses
Known Risks
- medium
- Mögliche Nebenwirkungen sind Übelkeit, Schwindel und dyskinetische Bewegungen.
Safer Use
- Start at a low dose.
- Regular medical supervision during long-term use.
Harm reduction tips do not replace medical advice.
Known Interactions
- MAO inhibitors
- Antipsychotics
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.
Gemeinsame Wirkungsmuster
Wirkungen, die L-DOPA mit verwandten Substanzen teilt.